8121 related articles for article (PubMed ID: 11898358)
1. [Prospects for developing treatment of uveal melanoma from the position of modern carcinogenesis concepts].
Likhvantseva VG
Vestn Oftalmol; 2002; 118(1):32-5. PubMed ID: 11898358
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
5. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
He YG; Mayhew E; Mellon J; Niederkorn JY
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
[TBL] [Abstract][Full Text] [Related]
6. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
Krvavica A; Talan-Hranilović J; Belicza M
Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
8. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
9. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
Rashid AB; Grossniklaus HE
Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
[TBL] [Abstract][Full Text] [Related]
10. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
Anurova OA; Likhvantseva VG; Vereshchagina MV
Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
Li H; Niederkorn JY; Neelam S; Alizadeh H
Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
Cai L; Li X; Zheng S; Wang Y; Wang Y; Li H; Yang J; Sun J
Melanoma Res; 2009 Feb; 19(1):1-7. PubMed ID: 19430401
[TBL] [Abstract][Full Text] [Related]
13. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
14. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
15. [Effect of bcl-2 antisense oligonucleotides on multidrug resistance of cultured uveal melanoma cells].
Guo LJ; Wu ZY; Zhang S; Zheng JL; Zheng HL
Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):73-6. PubMed ID: 12783683
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological implications of stroma pattern formation in uveal melanoma.
Clarijs R; Ruiter DJ; De Waal RM
J Cell Physiol; 2003 Mar; 194(3):267-71. PubMed ID: 12548547
[TBL] [Abstract][Full Text] [Related]
17. SPARC is expressed in human uveal melanoma and its abrogation reduces tumor cell proliferation.
Maloney SC; Marshall JC; Antecka E; Orellana ME; Fernandes BF; Martins C; Castiglione E; DI Cesare S; Logan P; Burnier MN
Anticancer Res; 2009 Aug; 29(8):3059-64. PubMed ID: 19661316
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin-D1 in uveal malignant melanoma.
Errico ME; Staibano S; Tranfa F; Bonavolonta G; Lo Muzio L; Somma P; Lucariello A; Mansueto G; D'Aponte A; Ferrara G; De Rosa G
Anticancer Res; 2003; 23(3B):2701-6. PubMed ID: 12894561
[TBL] [Abstract][Full Text] [Related]
20. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
